BANK VONTOBEL/CALL/EDWARDS LIFESCIENCES/72/0.1/20.09.24

BANK VONTOBEL/CALL/EDWARDS LIFESCIENCES/72/0.1/20.09.24 Share Price

DE000VM76JZ4

Market Closed - Boerse Frankfurt Warrants 11:32:02 28/06/2024 pm IST
2.1 ^EUR	-1.87%

Current month	+36.36%
1 month	+33.76%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart EDWARDS LIFESCIENCES CORPORATION

Chart BANK VONTOBEL/CALL/EDWARDS LIFESCIENCES/72/0.1/20.09.24

Latest news about EDWARDS LIFESCIENCES CORPORATION

Edwards Lifesciences Insider Sold Shares Worth $492,258, According to a Recent SEC Filing	21/06	MT
Edwards Lifesciences Corporation Announces Executive Changes	18/06	CI
Wolfe Research Adjusts Price Target on Edwards Lifesciences to $70 From $75	17/06	MT
Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR	05/06	BU

More news

Quotes 5-day view

Date	Price	Change
28/24/28	2.1	-1.87%
27/24/27	2.14	+8.63%
26/24/26	1.97	+4.23%
25/24/25	1.89	-1.05%
24/24/24	1.91	+1.60%

Real-time Boerse Frankfurt Warrants

Last update June 28, 2024 at 11:32 pm IST

More quotes

Static data

Product type	Warrants
Buy / Sell	CALL
Underlying	EDWARDS LIFESCIENCES CORPORATION
Issuer	Vontobel
WKN	VM76JZ
ISIN	DE000VM76JZ4
Date issued	08/01/2024
Strike	72 $
Maturity	20/09/2024 (83 Days)
Parity	10 : 1
Emission price	0.92 €
Emission volume	N/A
Settlement	Por diferencias
Currency	EUR

Technical Indicators

Highest since issue	2.5 €
Lowest since issue	0.83 €
Delta	0x
Omega	0.000000
Premium	0x
Gearing	6.4x
Moneyness	1.936
Difference Strike	-20.37 $
Difference Strike %	-28.29%
Spread	0.01 €
Spread %	0.49%
Intrinsic value	6.293
Present value	-4.257602

Company Profile

Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (67.9%); - hemodynamic monitoring systems (15.5%); - other (16.6%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).

Sector

More about the company